We lead the synthetic biology industry, having developed and successfully commercialized the most Lab-to-Market™ ingredients. Our sustainable ingredients are used in thousands of top global brands, including our own family of consumer brands in Clean Beauty and Health markets.
Amyris is covered by the following analysts.
Firm | Analyst |
---|---|
Cowen |
Steven Mah |
Jefferies |
Laurence Alexander |
Oppenheimer & Co. |
Colin Rusch |
H.C. Wainwright |
Amit Dayal |
J.P. Morgan |
Rachel Vatnsdal |
Piper Sandler |
Korinne Wolfmeyer |
Roth Capital Partners |
Craig Irwin |
Amyris is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Amyris's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Amyris or its management. Amyris does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.